The voice of Utah’s life sciences community

Medical Devices

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

BioUtah is the common voice and flag bearer for Utah’s life sciences industry, comprised of medical devices, pharmaceuticals, diagnostics, laboratories, research facilities, and biotechnology of all types. BioUtah connects industry with government, academia, capital markets, media, and service providers. Together we form an ecosystem that fosters collaboration, promotes innovation, and delivers technology that saves lives.

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

BIO Business Solutions

Savings achieved through this program on lab supplies, equipment, shipping and much more, often exceed the annual cost membership in BioUtah.

Bill Tracker

With the Utah legislature in session, follow the bills BioUtah is tracking that affect the life sciences industry.

Featured New Member

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents.

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

July 30, 2026

Canyon Labs Invests in Commercial Leadership to Give Medical Device Manufacturers Direct Access to Expertise

Canyon Labs strengthens its commitment to medical device manufacturers with strategic, direct-access leadership investments.

July 30, 2026

SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program

Southern Metrics is led by Chris Lyons, its Chief Executive Officer, an experienced medical technology executive and strategic advisor who has served on the SINTX Board of Directors since April 2025.

July 30, 2026

CancerVax Named a Top Preclinical Biotech Company of 2026 by Life Sciences Review

Independent industry recognition highlights the Company’s revolutionary immunotherapy platform and growing momentum in precision cancer treatment.

July 30, 2026

Biomerics Appoints Medical Device Industry Veteran Lokram Natarajan as Senior Vice President of Quality to Support Continued Global Growth

Global medical device quality executive brings more than 30 years of experience building high-performing organizations, advancing quality excellence and supporting scalable growth.

July 30, 2026

Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies

Company also completes proof of concept for the first blood-borne test for Ebola on Co-Dx PCR Pro ® instrument.

July 30, 2026

BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome

ReNU syndrome was discovered in 2024 and there are no medicines approved for the condition.

July 16, 2026

CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population

Company completes design and in-vitro validation of a single Smart mRNA that disguises cancer as multiple viral infections simultaneously to activate pre-existing T-cell immunity.

July 16, 2026

Halia Therapeutics Presents Two AAIC 2026 Posters on HT-4253 for Alzheimer’s Prevention in APOE4 Carriers

Preclinical data show HT-4253 reduces neuroinflammation and tau pathology; a second details a Phase 2a biomarker trial in pre-symptomatic APOE4 carriers via UAE genomics.

More BioUtah News